EUVIMEDDescobrir EUVIMED
Randomisierte kontrollierte StudieOpen access

Potential Harms of Feedback After Web-Based Depression Screening: Secondary Analysis of Negative Effects in the Randomized Controlled DISCOVER Trial

Mögliche Schäden durch Feedback nach webbasiertem Depressionsscreening: Sekundäranalyse negativer Effekte in der randomisierten kontrollierten DISCOVER-Studie

Franziska Sikorski iD, Bernd Löwe iD, Anne Daubmann iD, Sebastian Kohlmann iD

Journal of Medical Internet Research · 2025-04-30 · 27 · e59476

DOI: 10.2196/59476 ↗

Auf einen Blick

Bei 948 Teilnehmenden war Feedback nach webbasiertem Depressionsscreening nicht mit mehr Fehl- oder Überbehandlung, Symptomverschlechterung oder emotionaler Verschlechterung verbunden. Bei suizidalen Gedanken zeigte sich nach 1 Monat ein Signal für nicht maßgeschneidertes Feedback.

Fragestellung

Ist automatisiertes Feedback nach webbasiertem Depressionsscreening mit Fehl- oder Überbehandlung, Symptomverschlechterung oder Verschlechterung suizidaler Gedanken verbunden?

Methode

Sekundäranalyse der deutschen webbasierten randomisierten kontrollierten DISCOVER-Studie; Randomisierung 1:1:1 zu nicht maßgeschneidertem Feedback, maßgeschneidertem Feedback oder keinem Feedback; Vergleich der Risiken nach 1 und 6 Monaten.

Ergebnisse

Per-Protokoll-Sample: 948 Teilnehmende. Keine Unterschiede bei Fehldiagnose, Überbehandlung, Verschlechterung der Depressionsschwere, emotionaler Reaktion oder suizidalen Gedanken nach 6 Monaten (RRs 0,46 bis 1,96; P≥.13). Suizidgedanken nach 1 Monat: nicht maßgeschneidert 12,3 %, maßgeschneidert 8,1 %, kein Feedback 6,4 %; RR 1,92; P=.01.

Einschränkungen

Nur sekundäre Analyse; ein mögliches erhöhtes Risiko für Verschlechterung suizidaler Gedanken durch nicht maßgeschneidertes Feedback kann nicht ausgeschlossen werden.

Schlussfolgerung der Autor:innen

Die Ergebnisse sprechen dafür, dass Feedback nach webbasiertem Depressionsscreening nicht mit negativen Effekten wie Fehl- oder Überbehandlung oder Verschlechterungen verbunden ist. Für nicht maßgeschneidertes Feedback kann ein Risiko für suizidale Verschlechterung nicht ausgeschlossen werden.

Kernaussagen

  • Keine Unterschiede bei Fehl- oder Überbehandlung und Depressionsverschlechterung nach 6 Monaten
  • Suizidgedanken nach 1 Monat häufiger bei nicht maßgeschneidertem Feedback
  • Weitere prospektive Forschung zu negativen Effekten und Suizidalität nötig

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

At a glance

Randomisierte kontrollierte Studie in Journal of Medical Internet Research, published online on 2025-04-30. Written by Franziska Sikorski and 3 co-authors. Institution: Department of Psychosomatic Medicine and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Major MEDLINE topics: Depression, Feedback, Internet, Mass Screening. Cited 2 times so far (Crossref); 53 references. The full text is freely available in PubMed Central.

Auf einen BlickResumoSubjectsDados bibliográficosCiteRelated studies

Abstract (original language)

Background

Web-based depression screening followed by automated feedback of results is frequently used and promoted by mental health care providers. However, criticism points to potential associated harms. Systematic empirical evidence on postulated negative effects is missing.

Objective

We aimed to examine whether automated feedback after web-based depression screening is associated with misdiagnosis, mistreatment, deterioration in depression severity, deterioration in emotional response to symptoms, and deterioration in suicidal ideation at 1 and 6 months after screening.

Methods

This is a secondary analysis of the German-wide, web-based, randomized controlled DISCOVER trial. Affected but undiagnosed individuals screening positive for depression (9-item Patient Health Questionnaire [PHQ-9] ≥10 points) were randomized 1:1:1 to receive nontailored feedback, tailored feedback, or no feedback on their screening result. Misdiagnosis and mistreatment were operationalized as having received a depression diagnosis by a health professional and as having started guideline-based depression treatment since screening (self-report), respectively, while not having met the Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition) (DSM-V) criteria of a major depressive disorder at baseline (Structured Clinical Interview for DSM-V Disorders). Deterioration in depression severity was defined as a pre-post change of ≥4.4 points in the PHQ-9, deterioration in emotional response to symptoms as a pre-post change of ≥3.1 points in a composite scale of the Brief Illness Perception Questionnaire, and deterioration in suicidal ideation as a pre-post change of ≥1 point in the PHQ-9 suicide item. Outcome rates were compared between each feedback arm and the no feedback arm in terms of relative risks (RRs).

Results

In the per protocol sample of 948 participants (n=685, 72% female; mean age of 37.3, SD 14.1 years), there was no difference in rates of misdiagnosis (ranging from 3.5% to 4.9% across all study arms), mistreatment (7.2%-8.3%), deterioration in depression severity (2%-6.8%), deterioration in emotional response (0.7%-2.9%), and deterioration in suicidal ideation at 6 months (6.8%-13.1%) between the feedback arms and the no feedback arm (RRs ranging from 0.46 to 1.96; P values ≥.13). The rate for deterioration in suicidal ideation at 1 month was increased in the nontailored feedback arm (RR 1.92; P=.01) but not in the tailored feedback arm (RR 1.26; P=.43), with rates of 12.3%, 8.1%, and 6.4% in the nontailored, tailored, and no feedback arms, respectively. All but 1 sensitivity analyses as well as subgroup analyses for false-positive screens supported the findings.

Conclusions

The results indicate that feedback after web-based depression screening is not associated with negative effects such as misdiagnosis, mistreatment, and deterioration in depression severity or in emotional response to symptoms. However, it cannot be ruled out that nontailored feedback may increase the risk of deterioration in suicidal ideation. Robust prospective research on negative effects and particularly suicidal ideation is needed and should inform current practice. Trial Registration ClinicalTrials.gov NCT04633096; https://clinicaltrials.gov/study/NCT04633096; Open Science Framework 10.17605/OSF.IO/TZYRD; https://osf.io/tzyrd

Subjects

MeSH terms (MEDLINE)

DepressionFeedbackInternetMass ScreeningAdultFemaleHumansMaleMiddle AgedDiagnostic ErrorsGermanySecondary Data AnalysisSuicidal IdeationSurveys and Questionnaires

Author keywords

depressive disorderharmsmental healthmisdiagnosisnegative effectsoverdiagnosisrandomized controlled trialscreeningweb-based

Authors and institutions

  • Department of Psychosomatic Medicine and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Department of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Department of General Internal Medicine and Psychosomatics, University Medical Centre Heidelberg, Heidelberg, Germany.

ORCID profiles: Franziska Sikorski, Bernd Löwe, Anne Daubmann, Sebastian Kohlmann

Cite

APA

Sikorski, F., Löwe, B., Daubmann, A., & Kohlmann, S. (2025). Potential Harms of Feedback After Web-Based Depression Screening: Secondary Analysis of Negative Effects in the Randomized Controlled DISCOVER Trial. Journal of Medical Internet Research, 27, e59476. https://doi.org/10.2196/59476

Vancouver

Sikorski F, Löwe B, Daubmann A, Kohlmann S. Potential Harms of Feedback After Web-Based Depression Screening: Secondary Analysis of Negative Effects in the Randomized Controlled DISCOVER Trial. Journal of Medical Internet Research. 2025;27:e59476. doi:10.2196/59476

BibTeX
@article{Sikorski2025,
  author = {Sikorski, Franziska and Löwe, Bernd and Daubmann, Anne and Kohlmann, Sebastian},
  title = {Potential Harms of Feedback After Web-Based Depression Screening: Secondary Analysis of Negative Effects in the Randomized Controlled DISCOVER Trial},
  journal = {Journal of Medical Internet Research},
  year = {2025},
  volume = {27},
  pages = {e59476},
  doi = {10.2196/59476}
}
Start for free →